Filing Details
- Accession Number:
- 0001104659-17-006178
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-02 17:03:29
- Reporting Period:
- 2017-02-01
- Filing Date:
- 2017-02-02
- Accepted Time:
- 2017-02-02 17:03:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1640455 | Jounce Therapeutics Inc. | JNCE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1581954 | Duncan John Higgons | C/O Jounce Therapeutics, Inc. 1030 Massachusetts Avenue Cambridge MA 02138 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-01 | 6,700 | $16.00 | 27,025 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
